Min-Gyoo Seong
Algemeen Directeur bij Celliconlab, Inc.
Profiel
Min-Gyoo Seong is currently the Chief Executive Officer & Director at Celliconlab, Inc. He previously worked as an Auditor at Peptron, Inc. He holds a doctorate degree from the University of Tokyo.
Actieve functies van Min-Gyoo Seong
| Bedrijven | Functie | Begin |
|---|---|---|
Celliconlab, Inc.
 Celliconlab, Inc. Pharmaceuticals: MajorHealth Technology Celliconlab, Inc. is a South Korean bio-venture company that specializes in dermal delivery technology of topical-therapeutics. The company is based in Daejeon, South Korea. The company has developed a revolutionary peptide technology called Dermishuttle, which enables the delivery of cargos to the dermis by cell-to-cell transmission. This technology has contributed to the development of innovative therapeutics. The company was founded in 2012, and Min-Gyoo Seong has been the CEO of the company since 2011. | Algemeen Directeur | 01-01-2011 |
Eerdere bekende functies van Min-Gyoo Seong
| Bedrijven | Functie | Einde |
|---|---|---|
| PEPTRON, INC. | Comptroller/Controller/Auditor | - |
Opleiding van Min-Gyoo Seong
| University of Tokyo | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PEPTRON, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celliconlab, Inc.
Celliconlab, Inc. Pharmaceuticals: MajorHealth Technology Celliconlab, Inc. is a South Korean bio-venture company that specializes in dermal delivery technology of topical-therapeutics. The company is based in Daejeon, South Korea. The company has developed a revolutionary peptide technology called Dermishuttle, which enables the delivery of cargos to the dermis by cell-to-cell transmission. This technology has contributed to the development of innovative therapeutics. The company was founded in 2012, and Min-Gyoo Seong has been the CEO of the company since 2011. | Health Technology |
